Related Experiment Video
Updated: Oct 8, 2025

10:33
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.4K
Exosomal circRNAs: a new communication method in cancer
Jia-Lin Xu1,2, Wen-Xiu Xu1,2, Jin-Hai Tang1
1Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu, China.
American Journal of Translational Research
|December 27, 2021
Summary
Exosomal circular RNAs (circRNAs) are stable molecules found in body fluids, showing promise as early cancer diagnostic biomarkers and potential therapeutic targets for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Exosomes are key mediators of intercellular communication, carrying various biomolecules.
- Exosomal contents, including circular RNAs (circRNAs), play roles in cancer progression and development.
- circRNAs are stable, covalently closed RNA molecules accumulating in exosomes.
Purpose of the Study:
- To review the biogenesis and function of circRNAs.
- To explore the expression patterns of exosomal circRNAs in various cancers.
- To highlight the potential of exosomal circRNAs as cancer biomarkers and therapeutic targets.
Main Methods:
- Literature review on exosomal circRNA biogenesis and function.
- Analysis of studies reporting exosomal circRNA expression in cancer.
- Synthesis of evidence regarding diagnostic and therapeutic potential.
Main Results:
- Exosomal circRNAs are abundant and stable in body fluids.
- circRNAs are implicated in cancer cell growth, metastasis, angiogenesis, and development.
- Specific exosomal circRNA profiles are associated with different cancer types.
Conclusions:
- Exosomal circRNAs represent a novel class of biomarkers for early cancer detection.
- Targeting exosomal circRNAs offers a potential therapeutic strategy for cancer treatment.
Related Concept Videos
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Cancer Cell Migration through Invadopodia
2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K

